| Income Statement |
| Total Revenue | 12.96M |
|
| Revenues (USD) | 12.96M |
| Cost of Revenue | 9.62M |
| Gross Profit | 3.34M |
| Operating Expenses | 3.84M |
| Research and Development Expense | 1.04M |
| Selling, General and Administrative Expense | 2.80M |
| Operating Income | -504.00K |
| Interest Expense | 263.00K |
| Net Income | -766.00K |
| Net Income Common Stock | -766.00K |
| Net Income Common Stock (USD) | -766.00K |
| Consolidated Income | -766.00K |
| Earnings per Basic Share | -0.01 |
| Earnings per Basic Share (USD) | -0.01 |
| Earnings per Diluted Share | -0.01 |
| Earning Before Interest & Taxes (EBIT) | -503.00K |
| Earning Before Interest & Taxes (USD) | -503.00K |
| Weighted Average Shares | 70.63M |
| Weighted Average Shares Diluted | 70.63M |
| Balance Sheet |
| Cash and Equivalents | 573.00K |
| Cash and Equivalents (USD) | 573.00K |
| Trade and Non-Trade Receivables | 6.38M |
| Current Assets | 26.41M |
| Property, Plant & Equipment Net | 21.34M |
| Total Assets | 47.79M |
| Debt Current | 4.34M |
| Total Debt | 22.28M |
| Current Liabilities | 12.69M |
| Debt Non-Current | 17.94M |
| Total Liabilities | 30.83M |
| Accumulated Retained Earnings (Deficit) | -99.40M |
| Shareholders Equity | 16.97M |
| Shareholders Equity (USD) | 16.97M |
| Assets Non-Current | 21.38M |
| Total Debt (USD) | 22.28M |
| Deferred Revenue | 1.17M |
| Inventory | 17.56M |
| Liabilities Non-Current | 18.14M |
| Trade and Non-Trade Payables | 4.67M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 313.00K |
| Net Cash Flow from Financing | -1.70M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -715.00K |
| Capital Expenditure | -528.00K |
| Issuance (Purchase) of Equity Shares | 16.00K |
| Issuance (Repayment) of Debt Securities | -1.72M |
| Net Cash Flow from Investing | -528.00K |
| Net Cash Flow from Operations | 1.52M |
| Share Based Compensation | 83.00K |